In a groundbreaking revelation, the Global Anti-Neurofilament L Antibody Industry emerges as a beacon of transformative growth, propelled by a compelling Compound Annual Growth Rate (CAGR) of 11% from 2022 to 2032. Esteemed industry experts, in collaboration with Future Market Insights (FMI), forecast an extraordinary upsurge, propelling the market from its current valuation of US$ …